Capital World Investors

13F Holdings History for Allogene Therapeutics, Inc. - Common Stock (ALLO)

Symbol: ALLO on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 0 shares
Security Ownership: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Capital World Investors ownership in Allogene Therapeutics, Inc. Common Stock (ALLO)

2025-11-13 - Capital World Investors has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Allogene Therapeutics, Inc. Common Stock (ALLO). This represents 0% percent ownership of the company. In their previous filing dated 2025-05-13, Capital World Investors had reported owning 12.3M shares, indicating a decrease of -100% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Capital World Investors	0%	-93.3%		0	-12,265,330	-100%	$1.24	13G/A	9/30/2025	13 Nov 2025 19:06:13
Capital World Investors	5.6%		$16.8M	12.3M			$1.37	13G	3/31/2025	13 May 2025 11:44:13

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025		0%	$0	0	-11,150,000	-100%		Q3 2025
6/30/2025	0%	0%	$12.6M	11.2M	-1,115,330	-9.09%	$1.13	Q2 2025
3/31/2025	0%	+0%	$17.9M	12.3M	+5,368,778		$1.46	Q1 2025
12/31/2024	0%		$14.7M	6.9M			$2.13	Q4 2024
9/30/2024	0%		$19.3M	6.9M			$2.80	Q3 2024
6/30/2024	0%	+0%	$16.1M	6.9M	+6,896,552	NEW	$2.33	Q2 2024
3/31/2022		0%	$0	0	-1,300,000	-100%		Q1 2022
12/31/2021	0%	0%	$19.4M	1.3M	-946,576	-42.1%	$14.92	Q4 2021
9/30/2021	0.01%		$57.7M	2.25M	-1	0%	$25.70	Q3 2021
6/30/2021	0.01%		$58.6M	2.25M	-26	0%	$26.08	Q2 2021
3/31/2021	0.01%	0%	$79.3M	2.25M	-125,214	-5.28%	$35.30	Q1 2021
12/31/2020	0.01%	0%	$59.9M	2.37M	-293,869	-11%	$25.24	Q4 2020
9/30/2020	0.02%	-0.01%	$101M	2.67M	-815,438	-23.4%	$37.71	Q3 2020
6/30/2020	0.04%	+0.01%	$149M	3.48M	+503,460	+16.9%	$42.82	Q2 2020
3/31/2020	0.02%		$57.9M	2.98M			$19.44	Q1 2020
12/31/2019	0.02%	0%	$77.4M	2.98M	-298,021	-9.1%	$25.98	Q4 2019
9/30/2019	0.02%	+0%	$89.3M	3.28M	+501,104	+18.1%	$27.26	Q3 2019
6/30/2019	0.02%	+0%	$74.5M	2.77M	+603,098	+27.8%	$26.85	Q2 2019
3/31/2019	0.02%		$62.8M	2.17M			$28.91	Q1 2019
12/31/2018	0.02%	+0.02%	$58.5M	2.17M	+2,171,483	NEW	$26.93	Q4 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.